CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 605 enrolled
Drug / intervention
rapamycin-eluting Stent with permanent polymer +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00350454
NCT00350454Phase 4Completed
CompareCT.gov

Prospective, Randomized Trial of 3 Rapamycin-Eluting Stents With Different Polymer Coating Strategies For The Reduction of Coronary Restenosis (ISAR-TEST-3)

Deutsches Herzzentrum Muenchen·interventional·Posted Jul 10, 2006·Updated Jan 11, 2008

In Brief

A Phase 4 clinical trial evaluating rapamycin-eluting Stent with permanent polymer, rapamycin-eluting stent with biodegradable polymer, and 1 other intervention for Coronary Heart Disease. Completed, enrolled 605 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy of 3 different rapamycin-eluting-stent platforms to reduce coronary artery reblockage after stent implantation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Heart Disease
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 10, 2006
Enrollment StartJun 1, 2006
Primary CompletionSep 1, 2007
Study CompletionOct 1, 2007
TodayJul 1, 2026
Enrollment to primary: 1.3 yearsPosted 20.0 years ago

Interventions

rapamycin-eluting Stent with permanent polymerdevice

due to randomization, rapamycin-eluting stent with permanent polymer will be implanted

rapamycin-eluting stent with biodegradable polymerdevice

due to randomization, rapamycin-eluting stent with biodegradable polymer will be implanted

polymer-free, rapamycin-eluting stentdevice

due to randomization, polymer-free.rapamycin-eluting stent will be implanted